Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives"
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (15 May 2023) | Viewed by 17102
Special Issue Editor
2. Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy
Interests: lung cancer surgery; thoracic oncology; early-stage lung cancer; locally advanced lung cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue in Cancers: Body Composition in Oncology and Beyond
Special Issue Information
Lung cancer is the second most common cancer and the leading cause of cancer death among both men and women, making up almost 25% of all cancer deaths. Although it mainly occurs in older people, aged 70 or more, it may be diagnosed in younger patients, often with very aggressive features.
Historically, early-stage lung cancers have been approached by surgical resection in fit patients and by radiotherapy in fragile or high-risk patients not amenable to aggressive treatments; locally advanced lung cancer usually benefit from multimodal approaches, combining induction treatments, surgical resection and post-operative radiotherapy (until stage IIIA).
Stage IIIB patients are not treated by surgery, and only chemo-radiotherapy or other non-surgical treatments are taken into consideration. Stage IV patients (metastatic disease) do not benefit from surgery and are treated using chemotherapy, biological treatments, immunotherapy and radiotherapy when needed; moreover, thoracic surgeons may still play a role in controlling symptoms and treating or preventing life-threatening conditions (e.g., tracheal obstruction, cardiac tamponade from pericardial effusion, recurrent pleural effusion).
In this Special Issue, we would like to focus on the role of surgical treatment of lung cancer, ranging from radical approaches to early-stage lung cancer to combined approached to locally advanced tumors as well as palliative approaches for metastatic diseases.
It is our pleasure to lead such a comprehensive issue, and we look forward to receiving your valuable contribution.
Prof. Dr. Francesco Petrella
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- lung cancer surgery
- thoracic oncology
- early-stage lung cancer
- locally advanced lung cancer